Earnings: aTyr Pharma Losses Up $LIFE

aTyr Pharma, Inc., a bio-therapeutics company, has announce its first quarter results for FY-2015-16.

The results shows Net Loss widens from -$6.093 Million to -$9.071 Million YoY, while cash and cash reserves increased from %15.853 Million to $54.512 Million quarterly.

Yearly Quarter Comparison

Research & Development expenses Rise from $4.4 Million to $6.6 Million.

General and Admin Expenses also rise from $1.5 Million to $2.3 Million.

Prior to the private placement the Assets rose from $20.644 Million to $59.905 Million.

View the full earnings release here.